| Primary |
|
|
| Secondary |
| Renal Transplant |
19.5% |
| Immunosuppression |
18.8% |
| Conjunctivitis |
14.1% |
| Immunosuppressant Drug Therapy |
11.5% |
| Prophylaxis Against Transplant Rejection |
5.1% |
| Drug Use For Unknown Indication |
3.9% |
| Hypertension |
3.7% |
| Prophylaxis |
3.2% |
| Conjunctivoplasty |
2.9% |
| Liver Transplant |
2.7% |
| Transplant Rejection |
2.4% |
| Stem Cell Transplant |
2.0% |
| Thrombosis Prophylaxis |
2.0% |
| Antibiotic Prophylaxis |
1.7% |
| Pustular Psoriasis |
1.5% |
| Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis |
1.2% |
| Systemic Lupus Erythematosus |
1.2% |
| Dyslipidaemia |
1.0% |
| Lupus Nephritis |
1.0% |
| Corneal Transplant |
0.7% |
|
| Kidney Fibrosis |
14.3% |
| Systemic Candida |
12.2% |
| Brain Abscess |
6.1% |
| Keratitis Bacterial |
6.1% |
| Respiratory Failure |
6.1% |
| Streptococcal Infection |
6.1% |
| Vomiting |
6.1% |
| Deep Vein Thrombosis |
4.1% |
| Drug Ineffective |
4.1% |
| Escherichia Sepsis |
4.1% |
| Rebound Effect |
4.1% |
| Skin Necrosis |
4.1% |
| Sudden Death |
4.1% |
| Thrombotic Microangiopathy |
4.1% |
| Transplant Rejection |
4.1% |
| Arteriovenous Fistula Site Complication |
2.0% |
| Bladder Transitional Cell Carcinoma |
2.0% |
| Bursitis |
2.0% |
| Chronic Granulomatous Disease |
2.0% |
| Congenital Diaphragmatic Hernia |
2.0% |
|
| Concomitant |
| Renal Transplant |
29.0% |
| Product Used For Unknown Indication |
17.2% |
| Drug Use For Unknown Indication |
12.9% |
| Immunosuppression |
9.8% |
| Prophylaxis Against Transplant Rejection |
6.3% |
| Immunosuppressant Drug Therapy |
4.5% |
| Hypertension |
3.5% |
| Cardiac Failure Congestive |
2.3% |
| Gout |
1.5% |
| Pain |
1.5% |
| Upper Respiratory Tract Infection |
1.5% |
| Aspergillosis |
1.3% |
| Blood Pressure |
1.3% |
| Rhodococcus Infection |
1.3% |
| Type 2 Diabetes Mellitus |
1.3% |
| Bacterial Infection |
1.0% |
| Hyperlipidaemia |
1.0% |
| Renal Disorder |
1.0% |
| Transplant Rejection |
1.0% |
| Bronchopulmonary Aspergillosis |
0.8% |
|
| Kidney Fibrosis |
9.9% |
| Squamous Cell Carcinoma |
9.9% |
| Cardiac Pacemaker Insertion |
8.5% |
| Nephropathy Toxic |
8.5% |
| Thrombotic Microangiopathy |
8.5% |
| Death |
4.2% |
| Drug Ineffective |
4.2% |
| Hypotension |
4.2% |
| Nephritis |
4.2% |
| Pneumocystis Jiroveci Pneumonia |
4.2% |
| Renal Failure Acute |
4.2% |
| Renal Tubular Atrophy |
4.2% |
| Rhabdomyolysis |
4.2% |
| Sepsis |
4.2% |
| Visual Impairment |
4.2% |
| Drug Interaction |
2.8% |
| Hepatic Failure |
2.8% |
| Myopathy |
2.8% |
| Pain |
2.8% |
| Abscess Jaw |
1.4% |
|
| Interacting |
| Renal Transplant |
80.0% |
| Convulsion |
20.0% |
|
| Transplant Rejection |
100.0% |
|
